Position in MESO
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$1,538,061
+$1,283,410 QoQ
Shares Held
100,004
+608.4% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MESO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. MESO ranks #197 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in MESO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,538,061 | 100,004 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $254,651 | 14,116 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,795,604 | 111,459 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $136,114 | 12,499 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $456,792 | 36,602 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $5,756,414 | 290,728 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $148,146 | 18,133 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $136,710 | 20,075 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $58,556 | 11,688 | Shares | Defined | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||